Entrada Therapeutics Inc. (TRDA)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
6. 89
+0.02
+0.2911%
$
263.98M Market Cap
- P/E Ratio
- Div Yield
378,200 Volume
-2.5 Eps
$ 6.87
Previous Close 
Want to track TRDA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.03 |
| | | - | - |
| | | 0.14 | 1.55 |
| | | - | 0.68 |
| | | - | - |
| | | - | 1.02 |
TRDA Earnings Reports FAQ
What is the earnings per share (EPS) for TRDA?
The current EPS is -2.5.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately -97.06%, reflecting the TRDA's performance and NASDAQ (NMS) market conditions.
When is the next earnings release date?
Entrada Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Entrada Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for TRDA at this time, as Entrada Therapeutics Inc has no recent EPS data to calculate it.
